What Does a Breast Cancer Rash Look Like? Types & Signs

Breast cancer can produce several distinct types of rash, and no single description covers them all. The skin changes depend on whether the rash comes from the cancer itself or from treatment, and they range from a swollen, orange-peel texture across the breast to a scaly, eczema-like patch on the nipple to firm nodules scattered across the chest wall. Because many of these rashes closely resemble common benign conditions, recognizing the differences matters for catching something serious early.

Inflammatory Breast Cancer and the Orange-Peel Rash

The most widely discussed breast cancer rash belongs to inflammatory breast cancer, a rare but aggressive form of the disease. The hallmark appearance is redness, warmth, and thickened skin with a dimpled texture often described as “peau d’orange,” the French term for orange peel. The skin develops visible pits that look like the surface of a citrus fruit, caused by cancer cells blocking lymphatic drainage in the breast. The breast may also appear noticeably swollen, sometimes increasing an entire cup size or more over days to weeks.¹

What makes inflammatory breast cancer tricky is that it rarely produces a distinct lump. Instead, the redness and swelling can look almost identical to a breast infection. The cancer tends to appear in women in their forties and fifties, while acute mastitis usually shows up in younger women who are breastfeeding. That age and context difference is one of the most useful initial clues.² If a course of antibiotics does not clear up what looks like a breast infection, especially in a woman who is not lactating, inflammatory breast cancer should be investigated. The similarity is so close that even imaging can struggle to distinguish the two without specialized techniques.³

A survey of primary care providers found that they rated themselves only moderately confident in recognizing inflammatory breast cancer, and fewer than a third had ever suspected it in a patient. Over 44 percent incorrectly identified a palpable breast mass as one of its symptoms, when in fact the lack of a lump is part of what makes it so easy to miss.⁴ The takeaway is straightforward: redness, warmth, and swelling that don’t resolve with antibiotics within a week or two call for a biopsy, not another prescription.

Paget’s Disease and the Nipple Rash

A completely different kind of breast cancer rash shows up specifically on the nipple. Paget’s disease of the breast causes eczema-like changes to the nipple and the surrounding darker skin, including itching, redness, crusting, flaking, and sometimes small ulcers. It can look so much like common nipple eczema or contact dermatitis that some patients spend months applying steroid creams before anyone suspects cancer.⁵

In one reported case, a patient presented with a roughly 3 cm red plaque over the nipple with blurred edges, partial destruction of the nipple area, and nipple inversion, but no discharge or tenderness and no palpable mass underneath.⁶ That combination of visible skin damage without much pain and without an obvious lump is common in Paget’s disease and can lull both patients and doctors into treating it as a skin irritation. Underneath the surface, what’s happening is that cancerous cells from the milk ducts have migrated into the skin of the nipple itself.⁷

The critical red flag that separates Paget’s disease from ordinary eczema is persistence and one-sidedness. Regular nipple eczema usually affects both sides, responds to moisturizers or steroid creams, and comes and goes. Paget’s disease typically involves only one nipple, does not respond to topical treatment, and slowly worsens. A biopsy showing cancerous cells in the nipple skin, rather than the normal spongy inflammation pattern of eczema, confirms the diagnosis.⁸ Ultrasound of the nipple can also help: blood flow in the affected nipple is dramatically higher in Paget’s disease compared with simple dermatitis.⁹

Paget’s disease can also resemble melanoma on the nipple, which creates a further diagnostic puzzle. Laboratory staining of biopsy tissue helps sort this out: Paget’s cells test positive for markers associated with breast tissue and negative for the pigment-cell markers that melanoma produces.¹⁰

Cutaneous Metastasis and Skin Nodules

When breast cancer that has already been diagnosed (or sometimes not yet detected) spreads to the skin, the resulting rash can take a remarkably wide variety of forms. The most common presentation is firm, flesh-colored to red nodules, papules, or plaques on the chest wall or on the breast itself.¹¹ In one case series, about two thirds of patients with skin metastasis had these nodular lesions.¹²

But the nodules are only the beginning. Cutaneous metastases from breast cancer also come in several named patterns that look very different from each other:

Carcinoma erysipelatoides: red, warm, swollen patches that look like the skin infection cellulitis, sometimes with a sharp border.
Carcinoma telangiectoides: tiny dilated blood vessels clustered on the skin, sometimes with a purplish discoloration.
Carcinoma en cuirasse: a rare and striking pattern where the skin of the chest becomes thickened, hardened, and almost armor-like, with diffuse scarring and tightness that can restrict breathing.

Carcinoma en cuirasse can also appear alongside rashes that follow the path of a nerve, mimicking shingles.¹³ Skin metastases have been documented masquerading as dermatitis, cysts, hives, hair loss, herpes, and even a red bump on the tip of the nose. They can appear not only on the breast and chest wall but also in surgical scars, radiation treatment areas, the scalp, and the eyelids.¹¹

The variety is the point. There is no single rash to look for with cutaneous metastasis. Any new, unexplained skin lesion in someone with a history of breast cancer, especially one that doesn’t respond to standard treatments, warrants investigation.

Treatment-Related Rashes

Not every breast cancer rash is caused by the cancer itself. Many of the skin changes patients experience come from treatment: surgery, radiation, and systemic drugs can all produce rashes that need to be recognized for what they are, partly so they can be managed and partly so they aren’t confused with disease progression.

Radiation Dermatitis

Radiation therapy to the breast causes skin reactions in two time frames. Acute radiation dermatitis develops within days to weeks of treatment and typically includes redness, peeling, and blistering in the treatment area, much like a severe sunburn. Chronic radiation dermatitis develops months to years later and looks quite different: the skin may become permanently thickened or fibrotic, take on darker or lighter pigmentation, or develop tiny visible blood vessels called telangiectasias.¹⁴ The chronic changes are generally cosmetic rather than dangerous, but they can sometimes be mistaken for new disease.

Drug-Related Skin Reactions

Newer breast cancer therapies, including immune checkpoint inhibitors, targeted therapies, and antibody-drug conjugates, frequently cause skin side effects. These can include generalized rash, itching, dry skin, redness, changes in skin or nail color, and mouth sores.¹⁵ One study of patients receiving ribociclib, a targeted therapy used for metastatic breast cancer, found that roughly a quarter developed some kind of skin reaction, with itching, red patches, eczema-like rash, and hives among the most common patterns. Most were mild to moderate, but rare severe reactions including toxic epidermal necrolysis, a life-threatening skin-peeling condition, were also reported.¹⁶

Antibody-drug conjugates, a class of treatments that deliver chemotherapy directly to cancer cells via an antibody, can cause rash, itching, dryness, redness, pigment changes, and nail problems. The mechanism likely involves the chemotherapy payload affecting rapidly dividing skin cells as an off-target effect. Most of these reactions respond well to moisturizers, gentle skin care, and topical treatments, and rarely require stopping the drug.¹⁷

Knowing that a rash is treatment-related rather than a sign of cancer progression can spare patients considerable anxiety. If you’re on breast cancer therapy and develop a new rash, your oncology team should be the first call rather than a search engine.

What Changes Across Skin Tones

Much of the clinical literature on breast cancer rashes describes what they look like on lighter skin, which creates a real visibility gap. Redness is the classic early sign of inflammatory breast cancer and several treatment-related rashes, but on darker skin, redness may not be obvious at all. Instead, changes may present as areas of darker pigmentation, a purplish hue, or textural changes like thickening and warmth without a clear color shift. One case documented a patient with deep skin tone who developed thickened plaques with a purple hue and widespread areas of both darkened and lightened skin during breast cancer treatment.¹⁸

The practical implication is that if you have a darker complexion and notice breast skin that feels different, looks shinier, feels warmer, or has changed color in any direction, those signs deserve the same attention as the “redness” that medical textbooks emphasize. Waiting for the textbook red rash could mean waiting too long.

Stewart-Treves Syndrome

Years or even decades after breast cancer treatment, a rare and dangerous skin condition called Stewart-Treves syndrome can develop. It arises in limbs affected by chronic lymphedema, the persistent swelling that sometimes follows surgery to remove lymph nodes or radiation therapy. The syndrome involves the development of an angiosarcoma, a cancer of blood or lymph vessel walls, in the swollen limb. Over 90 percent of reported cases involve the arm on the same side as the breast surgery.¹⁹

The rash typically appears as purplish or violet-colored nodules or patches on the swollen arm. Early on, these lesions are often mistaken for bruises, cellulitis, or other benign conditions. In a case series of patients who developed the syndrome after breast cancer surgery and radiation, all initially presented with violaceous or nodular lesions on their chronically swollen limbs, and all were initially misdiagnosed.²⁰ Stewart-Treves syndrome is extremely rare, with only around 400 cases in the entire medical literature, but it is lethal if not caught early. Anyone with chronic arm swelling after breast cancer treatment who notices new purple or dark-colored skin changes should seek evaluation promptly.

When to Push for a Biopsy

Across every type of breast cancer rash, a consistent theme emerges: the skin changes mimic common benign conditions, and the risk lies in accepting the benign explanation too long. A few patterns should raise your suspicion enough to ask specifically for a biopsy rather than another topical cream:

Breast redness or swelling that does not resolve with antibiotics: especially in a woman over 40 who is not breastfeeding, this should prompt investigation for inflammatory breast cancer.
A nipple rash on one side only that does not clear with steroid cream: persistent, one-sided nipple changes that worsen over weeks suggest Paget’s disease rather than eczema.
New firm nodules on the chest wall or breast skin: in anyone with a breast cancer history, unexplained lumps in or under the skin need biopsy regardless of how benign they look.
Purple or bruise-like patches on a chronically swollen arm: especially years after breast surgery, these need to be evaluated for angiosarcoma.
A treatment-related rash that changes character or keeps growing: while most drug and radiation rashes are mild, any rapid progression or failure to respond to standard management deserves re-evaluation.

The difficulty of self-diagnosing any of these conditions is compounded by the fact that many cancer-related rashes don’t hurt much, at least initially. Paget’s disease may itch but often isn’t painful. Inflammatory breast cancer causes warmth and swelling but can be relatively comfortable early on. Cutaneous metastases may be completely painless. Pain is not a reliable signal here; visual and textural changes in the skin are more informative than how the area feels.

How Doctors Distinguish These Rashes

If you do get referred for evaluation, the diagnostic pathway depends on which type of rash is suspected. For inflammatory breast cancer, diagnosis combines clinical examination with imaging and skin biopsy. MRI has shown promise in distinguishing inflammatory breast cancer from mastitis and other conditions that look similar, though the diagnosis ultimately rests on finding cancer cells in the skin biopsy that show they have invaded the lymphatic channels of the breast skin.³

For suspected Paget’s disease, the approach starts with a biopsy of the nipple skin. Under the microscope, the pathologist looks for large, distinctive cancer cells that have migrated into the outer layer of nipple skin, a pattern that looks nothing like the spongy inflammation of eczema.⁸ Special staining can then confirm whether those cells come from breast tissue rather than from a melanoma or other skin cancer.¹⁰

For cutaneous metastases, a punch biopsy of any suspicious skin lesion is the standard first step. Given how many different forms these metastases can take, pathology is the only reliable way to determine whether a new skin change represents cancer spread, a treatment side effect, or something entirely unrelated. The diagnosis almost always comes from the microscope, not from the appearance alone.

The Misdiagnosis Problem

The resemblance between breast cancer rashes and everyday skin conditions is not just an academic concern. Real diagnostic delays happen because of it. Inflammatory breast cancer is misdiagnosed as mastitis or dermatitis frequently enough that clinical guidelines specifically warn about the overlap.¹ Paget’s disease of the nipple is treated as eczema for months before anyone biopsies the area.⁵ Stewart-Treves syndrome presents as what looks like a bruise and gets written off until it’s advanced.

The survey of primary care providers that found low confidence in recognizing inflammatory breast cancer also revealed that since the COVID-19 pandemic started, over 60 percent reported delays in breast cancer referrals, and a third reported diagnosing less breast cancer overall.⁴ These systemic gaps make patient awareness more important, not less. You do not need to be able to diagnose yourself, but knowing that breast cancer can look like a rash rather than a lump gives you the vocabulary to ask the right questions and push back if a prescribed cream isn’t working.

1
PubMed Central. Inflammatory breast carcinoma
2
PubMed. Differentiating inflammatory breast cancer from acute mastitis
3
PubMed. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis
4
PubMed Central. Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and management
5
PubMed Central. Multimodal Imaging Detection of Difficult Mammary Paget Disease: Dermoscopy, Reflectance Confocal Microscopy, and Line-Field Confocal-Optical Coherence Tomography
6
PubMed Central. Dermoscopy of Mammary Paget’s Disease: A Case Report and Literature Review – Section: Case presentation
7
International Journal of Surgery Case Reports. Extensive Paget’s disease of the nipple: Case report – Section: Discussion
8
PubMed. ‘Eczematous’ dermatitis of the nipple: clinical and histopathological differential diagnosis of Paget disease
9
PubMed Central. Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions
10
PubMed Central. Dermatologic Mimickers of Paget’s Disease of the Breast: A Systematic Review – Section: Results
11
PubMed Central. Pleomorphic Appearance of Breast Cancer Cutaneous Metastases
12
PubMed Central. Skin Metastasis in Breast Cancer Patients; a Case Series – Section: Results
13
Cancer Research and Cellular Therapeutics. Carcinoma en cuirasse associated to zosteriform metastasis from breast adenocarcinoma
14
PubMed Central. Chronic radiation-induced dermatitis: what is new in 2024? A narrative review
15
PubMed. New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer Therapies
16
PubMed Central. Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast Cancer – Section: Results
17
PubMed Central. Toxicities of Antibody–Drug Conjugates in Breast Cancer: From Mechanistic Insights to Clinical Management – Section: Major Toxicities of ADCs
18
British Journal of Dermatology. BI21 The development of diffuse extragenital lichen sclerosus in a patient on palbociclib and fulvestrant for metastatic breast cancer
19
PubMed Central. Stewart-Treves syndrome – Section: Discussion
20
PubMed Central. Stewart Treves syndrome as a catastrophic sequela of chronic lymphedema: Clinical spectrum, management challenges, and outcomes – Section: Results